drugset / Trial / NCT02340130
Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
RandomizedSingle-groupOpen-labelTreatment
Summary
This is an open-label, non-controlled, non-randomised, prospective safety study in patients with rhinitis or allergic rhinoconjunctivitis, with controlled asthma, and clinically relevant sensitisation to dust mites from the Pyroglyphidae and Glycyphagidae families.
Timeline
- Start
- 2014-09
- Primary completion
- 2018-05
- Completion
- 2018-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DP/MG/14-1 | Unknown | — | — |
| Subject | DP/MG/14-2 | Unknown | — | — |